- Author:
Zhimin CHEN
1
;
Junfen FU
1
;
Qiang SHU
1
;
Wei WANG
1
;
Yinghu CHEN
1
;
Chunzhen HUA
1
;
Fubang LI
1
;
Ru LIN
1
;
Lanfang TANG
1
;
Tianlin WANG
1
;
Yingshuo WANG
1
;
Weize XU
1
;
Zihao YANG
1
;
Sheng YE
1
;
Tianming YUAN
1
;
Chenmei ZHANG
1
;
Yuanyuan ZHANG
1
Author Information
- Publication Type:Journal Article
- MeSH: Betacoronavirus; isolation & purification; Child; Coronavirus Infections; diagnosis; pathology; therapy; Humans; Pandemics; Pneumonia, Viral; diagnosis; diagnostic imaging; etiology; pathology; therapy
- From: Journal of Zhejiang University. Medical sciences 2020;49(2):139-146
- CountryChina
- Language:Chinese
- Abstract: The coronavirus disease 2019 (COVID-19) has caused a global pandemic. All people including children are generally susceptible to COVID-19, but the condition is relatively mild for children. The diagnosis of COVID-19 is largely based on the epidemiological evidence and clinical manifestations, and confirmed by positive detection of virus nucleic acid in respiratory samples. The main symptoms of COVID-19 in children are fever and cough; the total number of white blood cell count is usually normal or decreased; the chest imaging is characterized by interstitial pneumonia, which is similar to other respiratory virus infections and infections. Early identification, early isolation, early diagnosis and early treatment are important for clinical management. The treatment of mild or moderate type of child COVID-19 is mainly symptomatic. For severe and critical ill cases, the oxygen therapy, antiviral drugs, antibacterial drugs, glucocorticoids, mechanical ventilation or even extracorporeal membrane oxygenation (ECMO) may be adopted, and the treatment plan should be adjusted timely through multi-disciplinary cooperation.